A new global clinical trial is launching to test if a common anti-inflammatory drug colchicine can prevent serious complications caused by the novel coronavirus. The study, which will recruit 6,000 participants from the US, Canada and Europe, will examine colchicine. Colchicine is most often used to treat gout, a complex form of arthritis that causes … Read more
Tocilizumab, marketed as Actemra, will be given to hundreds of critically ill coronavirus patients in the NHS Hundreds of critically ill coronavirus patients in the NHS will be given an arthritis drug as part of the world’s largest trial of promising therapies. Tocilizumab, sold as RoActemra or Actemra, will be administered to patients whose lungs … Read more
Trials of a vaccine that could protect against the coronavirus are set to begin in the UK. Work on the vaccine, developed by clinical teams at the Oxford University’s Jenner Institute and Oxford Vaccine Group, began in January. Now a study involving up to 510 healthy volunteers between 18 and 55 is to get started. … Read more
Disney Plus is currently treating customers to a free seven-day trial, allowing all UK residents the chance to experience the magic the streaming service has to offer. To access your Disney Plus seven-day free trial, all you need to do is sign up and choose from either the £5.99 per month plan or the £59.99 annual … Read more
More than 5,000 people in Britain have volunteered to take part in a pioneering drug trial in search of a treatment for the currently incurable COVID-19. The Recovery Trial, conducted by Oxford University, recruited the participants — all of whom are COVID-19 patients already in hospital — at more than 160 NHS hospitals. Participants will … Read more
Remdesivir anti-viral trial reports ‘rapid recoveries’ for severe hospitalised coronavirus patients with ‘nearly all’ discharged within a week. University of Chicago Medicine recruited 125 people with COVID-19 as part of Gilead Science’s clinical trials. Of those people, 113 had severe disease. All the patients were been treated with daily infusions of remdesivir. Most of them … Read more
The first results from an international experimental US antiviral drug are promising, even as a trial of the same drug in China shuts down. More than half of a group of severely ill coronavirus patients from the US, Canada, Europe and Japan improved after taking remdesivir made by California-based Gilead Sciences. Originally developed as a … Read more
Scientists in Brazil have stopped part of a study of a malaria drug touted as a possible coronavirus treatment after heart rhythm problems developed in one-quarter of people given the higher of two doses being tested. Chloroquine and a newer, similar drug called hydroxychloroquine, have been pushed by President Donald Trump after some early tests … Read more
A pharmaceutical firm will donate two million antimalarials to the world’s largest COVID-19 medication trial following Donald Trump’s praise of the drug. Accord Healthcare Ltd, a global medicine distributor, will supply hydroxychloroquine to 40,000 frontline healthcare workers in the COPCOV study. They will take a hydroxychloroquine tablet daily and be followed for a five-month period to … Read more
The second vaccine safety trial for coronavirus is underway in the US using a skin-deep shot instead of the usual deeper jab injected into the muscle. The pinch should feel like a simple skin test, a researcher told one of the 40 volunteers lying on an exam table in Kansas City, Missouri, on Wednesday. ‘It’s … Read more